Q linea AB - Asset Resilience Ratio

Latest as of December 2025: 69.82%

Q linea AB (QLINEA) has an Asset Resilience Ratio of 69.82% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr258.11 Million

≈ $27.78 Million USD Cash + Short-term Investments

Total Assets

Skr369.67 Million

≈ $39.78 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Q linea AB's Asset Resilience Ratio has changed over time. Check how strategically is Q linea AB's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Q linea AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see QLINEA company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr258.11 Million	69.82%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr258.11 Million	69.82%

Asset Resilience Insights

Very High Liquidity: Q linea AB maintains exceptional liquid asset reserves at 69.82% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Q linea AB Industry Peers by Asset Resilience Ratio

Compare Q linea AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Sinocare Inc SHE:300298	Medical Devices	3.53%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Bactiguard Holding AB (publ) ST:BACTI-B	Medical Devices	8.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%

Annual Asset Resilience Ratio for Q linea AB (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Q linea AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	69.82%	Skr258.11 Million ≈ $27.78 Million	Skr369.67 Million ≈ $39.78 Million	+52.48pp
2024-12-31	17.34%	Skr25.66 Million ≈ $2.76 Million	Skr147.99 Million ≈ $15.93 Million	-17.98pp
2023-12-31	35.33%	Skr81.95 Million ≈ $8.82 Million	Skr231.98 Million ≈ $24.96 Million	+0.08pp
2022-12-31	35.24%	Skr73.09 Million ≈ $7.87 Million	Skr207.39 Million ≈ $22.32 Million	-0.34pp
2021-12-31	35.58%	Skr166.03 Million ≈ $17.87 Million	Skr466.63 Million ≈ $50.22 Million	-38.86pp
2020-12-31	74.45%	Skr306.89 Million ≈ $33.03 Million	Skr412.23 Million ≈ $44.36 Million	+19.30pp
2019-12-31	55.15%	Skr206.48 Million ≈ $22.22 Million	Skr374.41 Million ≈ $40.29 Million	-38.43pp
2018-12-31	93.58%	Skr504.44 Million ≈ $54.29 Million	Skr539.07 Million ≈ $58.01 Million	+57.77pp
2017-12-31	35.81%	Skr6.59 Million ≈ $708.97K	Skr18.40 Million ≈ $1.98 Million	--

pp = percentage points

About Q linea AB

ST:QLINEA Sweden Medical Devices

Market Cap

$37.72 Million

Skr350.55 Million SEK

Market Cap Rank

#22901 Global

#435 in Sweden

Share Price

Skr18.50

Change (1 day)

+0.82%

52-Week Range

Skr14.85 - Skr54.20

All Time High

Skr176.50